These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

111 related items for PubMed ID: 3774563

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Antiarrhythmic and electrophysiologic actions of bethanidine sulfate in primary ventricular fibrillation or life-threatening ventricular tachycardia.
    Benditt DG, Benson DW, Dunnigan A, Kriett JM, Pritzker MR, Bacaner MB.
    Am J Cardiol; 1984 May 01; 53(9):1268-74. PubMed ID: 6711426
    [Abstract] [Full Text] [Related]

  • 3. Bethanidine sulfate: efficacy in prevention of ventricular tachyarrhythmias during programmed stimulation. Report of a multicenter study of 56 patients.
    Teichman SL, Waspe LE, Matos JA, Kim SG, Fisher JD.
    J Am Coll Cardiol; 1985 Sep 01; 6(3):510-7. PubMed ID: 3897340
    [Abstract] [Full Text] [Related]

  • 4. Antiarrhythmic action of bethanidine.
    Somberg JC, Butler B, Torres V, Flowers D, Tepper D, Wynn J, Keren G, Miura DS.
    Am J Cardiol; 1984 Aug 01; 54(3):343-6. PubMed ID: 6465015
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Antiarrhythmic, antifibrillatory, and hemodynamic actions of bethanidine sulfate: an orally effective analog of bretylium for suppression of ventricular tachyarrhythmias.
    Bacaner MB, Benditt DG.
    Am J Cardiol; 1982 Oct 01; 50(4):728-34. PubMed ID: 6812406
    [Abstract] [Full Text] [Related]

  • 7. Meobentine sulfate: antiarrhythmic and electrophysiologic effects assessed by programmed electrical stimulation and ambulatory monitoring in patients with complex ventricular tachyarrhythmia. Report of a multicenter evaluation.
    Anderson JL, Reid PR, Platia EV, Akhtar M, Ruskin JN, Schaal SF, Jueng P, Long RA, Wenger TL.
    Am Heart J; 1985 Oct 01; 110(4):774-84. PubMed ID: 3901715
    [Abstract] [Full Text] [Related]

  • 8. Development of ventricular tachyarrhythmias in the conscious canine during the recovery phase of experimental ischemic injury: effect of bethanidine administration.
    Patterson E, Amalfitano DJ, Lucchesi BR.
    J Cardiovasc Pharmacol; 1984 Oct 01; 6(3):470-5. PubMed ID: 6202974
    [Abstract] [Full Text] [Related]

  • 9. Antidysrhythmic actions of meobentine sulfate.
    Zimmerman JM, Patterson E, Pitt B, Lucchesi B.
    Am Heart J; 1984 Jun 01; 107(6):1117-24. PubMed ID: 6720538
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Programmed ventricular stimulation for arrhythmia risk prediction in patients with idiopathic dilated cardiomyopathy and nonsustained ventricular tachycardia.
    Grimm W, Hoffmann J, Menz V, Luck K, Maisch B.
    J Am Coll Cardiol; 1998 Sep 01; 32(3):739-45. PubMed ID: 9741521
    [Abstract] [Full Text] [Related]

  • 14. Encainide in lethal ventricular arrhythmias evaluated by electrophysiologic testing and decrease in symptoms.
    Horowitz LN.
    Am J Cardiol; 1986 Aug 29; 58(5):83C-86C. PubMed ID: 3092624
    [Abstract] [Full Text] [Related]

  • 15. Ischemia-induced conduction delay and ventricular arrhythmias: comparative electropharmacology of bethanidine sulfate and bretylium tosylate.
    Kabell G.
    J Cardiovasc Pharmacol; 1989 Mar 29; 13(3):471-82. PubMed ID: 2471895
    [Abstract] [Full Text] [Related]

  • 16. Amiodarone in the management of patients with ventricular tachycardia and ventricular fibrillation.
    Morady F, Scheinman MM, Hess DS.
    Pacing Clin Electrophysiol; 1983 May 29; 6(3 Pt 1):609-15. PubMed ID: 6191299
    [Abstract] [Full Text] [Related]

  • 17. A dual electrophysiologic test for atrial antireentry and ventricular antifibrillatory studies. Effects of bethanidine, procainamide, and WY-48986.
    Wu KM, Hunter TL, Proakis AG.
    J Pharmacol Methods; 1990 Apr 29; 23(2):87-95. PubMed ID: 2332983
    [Abstract] [Full Text] [Related]

  • 18. Long-term reproducibility of electrophysiologically guided therapy with sotalol in patients with ventricular tachyarrhythmias.
    Mewis C, Kühlkamp V, Mermi J, Bosch RF, Seipel L.
    J Am Coll Cardiol; 1999 Jun 29; 33(7):1989-95. PubMed ID: 10362204
    [Abstract] [Full Text] [Related]

  • 19. Dofetilide reduces the frequency of ventricular arrhythmias and implantable cardioverter defibrillator therapies.
    Baquero GA, Banchs JE, Depalma S, Young SK, Penny-Peterson ED, Samii SM, Wolbrette DL, Naccarelli GV, Gonzalez MD.
    J Cardiovasc Electrophysiol; 2012 Mar 29; 23(3):296-301. PubMed ID: 21955243
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.